Allergy in India-a call for submissions

Robert J Boyle¹, Mamidipudi T Krishna², Mohamed H Shamji^{1

3}

Affiliations

¹ National Heart and Lung Institute, Imperial College London, London, UK.
² University Hospitals Birmingham NHS Foundation Trust and Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
³ NIHR Imperial Biomedical Research Centre, London, UK.

Editorial

Robert J Boyle et al. Clin Exp Allergy. 2022 Mar.

. 2022 Mar;52(3):364-366.

doi: 10.1111/cea.14111.

Robert J Boyle¹, Mamidipudi T Krishna², Mohamed H Shamji^{1

3}

¹ National Heart and Lung Institute, Imperial College London, London, UK.
² University Hospitals Birmingham NHS Foundation Trust and Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
³ NIHR Imperial Biomedical Research Centre, London, UK.

No abstract available

References

1. Bermingham WH, Bhogal R, Audi Nagarajan S, et al. Practical management of suspected hypersensitivity reactions to anti-tuberculosis drugs. Clin Exp Allergy. 2021.
1. Parthasarathi A, Padukudru S, Rajgopal N, Holla AD, Krishna MT, Mahesh PA. Allergic disease prevalence in schoolchildren in Bengaluru, India: A cross-sectional survey. Clin Exp Allergy. 2021;51(7):955-958.
1. Mahoney J, Hew M, Vertigan A, Oates J. Treatment effectiveness for Vocal Cord Dysfunction in adults and adolescents: A systematic review. Clin Exp Allergy. 2021.
1. de Lusignan S, Alexander H, Broderick C, et al. Patterns and trends in eczema management in UK primary care (2009-2018): A population-based cohort study. Clin Exp Allergy. 2021;51(3):483-494.
1. de Lusignan S, Alexander H, Broderick C, et al. The epidemiology of eczema in children and adults in England: A population-based study using primary care data. Clin Exp Allergy. 2021;51(3):471-482.